Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Learn which credit cards provide the best reward points and how to maximize their value. Enhance your rewards strategy.
28,145 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Investors looking at cannabis real estate need to understand how Innovative Industrial Properties reports earnings. T...
As 2026 approaches, home prices are testing the balance between demand and supply. This guide unpacks what to expect,...
A high-profile rift between two longtime mentors-turned-critics shines a light on how money, branding, and risk manag...
A senior comms exec says AI notetakers are moving from convenience to liability as governance gaps and confidential n...
A common bond-ETF choice in taxable accounts can quietly erode retirement income through taxes. A simple, two-minute ...
When kevin warsh's inflation testimony landed, traders priced an 86% chance of a Fed rate hold. This article breaks d...
Forget intel. executives cashing has raised caution among traders, but the AI demand backdrop remains intact. This pi...
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
When Berkshire Hathaway's Greg Abel shifts course, investors sit up. This piece breaks down why he trimmed Amazon and...
As SpaceX hit the public markets, 29 wall street analysts priced in a future packed with satellite internet, reusable...
Chemed has faced a challenging year, even as its business lines stay essential. This article breaks down the drivers ...